Although a previous study found an association between anti-Ro-52 autoantibodies and ILD, potentially leading to worse outcomes in IIM patients (40), the two patients in our cohort who tested strongly positive for SAE1 autoantibodies with coexisting anti-Ro-52 autoantibodies did not exhibit a rapid progressive ILD disease course. This evidence concerns the gene SAE1 and interstitial lung disease.